Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: ADAPTIVE BIOTECHNOLOGIES CORPORATION
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-05-07 to 2024-09-30
Current total value of award: $61150
Description: SARS-COV-2 IMMUNOSEQUENCING TESTING SERVICES